SARS-CoV-2-IN-33
Product Specifications
UNSPSC Description
SARS-CoV-2-IN-33 (compound 3m) is a COVID-19 inhibitor. SARS-CoV-2-IN-33 shows anti-proliferative activity against cancer cells. SARS-CoV-2-IN-33 exhibits comparatively good binding affinity (-8.0 Kcal/mole) to COVID-19 main protease (Mpro) (PDB ID: 6LU7). SARS-CoV-2-IN-33 can be used in studies of cancer and COVID-19[1].
Target Antigen
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-33.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(C2=C(N(C3=CC=CC=C3)N=C2C)O)C4=CC(OC)=C(C(OC)=C4)OC)C(C)=NN1C5=CC=CC=C5
Molecular Weight
526.58
References & Citations
[1]Gupta A, et al. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4, 4’-(Arylmethylene) bis (1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro. ACS Omega, 2022.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-151478/SARS-CoV-2-IN-33-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-151478/
Clinical Information
No Development Reported
CAS Number
299919-79-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items